These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24409596)

  • 1. Diagnostics for superbugs.
    Raich TJ; Powell S
    MLO Med Lab Obs; 2013 Dec; 45(12):44, 46. PubMed ID: 24409596
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done.
    Murray PR
    MLO Med Lab Obs; 2013 May; 45(5):26, 28, 30. PubMed ID: 23763046
    [No Abstract]   [Full Text] [Related]  

  • 3. Establishing surveillance for carbapenem-resistant Enterobacteriaceae in Minnesota, 2012.
    Shaw KM; Harper JE; Vagnone PS; Lynfield R
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):451-3. PubMed ID: 24602959
    [No Abstract]   [Full Text] [Related]  

  • 4. "Nightmare" bacteria on the rise in US hospitals, long-term care facilities.
    Kuehn BM
    JAMA; 2013 Apr; 309(15):1573-4. PubMed ID: 23592085
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors.
    Dirajlal-Fargo S; DeBiasi R; Campos J; Song X
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):447-9. PubMed ID: 24602957
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
    Ho CM; Ho MW; Liu YC; Toh HS; Lee YL; Liu YM; Huang CC; Lu PL; Liu CE; Chen YH; Ko WC; Tang HJ; Yu KW; Chen YS; Chuang YC; Wang JH; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S24-8. PubMed ID: 22749055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of enterobacteria to carbapenem antibiotics is a global crisis.
    Tanne JH
    BMJ; 2012 Mar; 344():e1646. PubMed ID: 22396112
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbapenemase-producing Enterobacteriaceae: a call for action!
    Nordmann P; Cornaglia G
    Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).
    Basu S; Singh AK; Nair GB
    Natl Med J India; 2010; 23(5):261-2. PubMed ID: 21250578
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbapenem-resistant Enterobacteriaceae: a growing threat.
    Nursing; 2013 Jul; 43(7):65. PubMed ID: 23778218
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot testing of an out-of-country medical care questionnaire with screening and cost analysis of preemptive isolation for carbapenem-resistant Enterobacteriaceae in a large Canadian health region.
    Rajapakse N; Vayalumkal J; Lam-Li D; Pearce C; Rees G; Kamhuka L; Peirano G; Pidhorney C; Ledgerwood D; Alfieri N; Hope K; Gregson D; Pitout J; Louie T; Conly J
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):450-1. PubMed ID: 24602958
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):290-1. PubMed ID: 22521054
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbapenem-resistant Enterobacteriaceae: a call for cultural change.
    Palmore TN; Henderson DK
    Ann Intern Med; 2014 Apr; 160(8):567-9. PubMed ID: 24733200
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beware of nightmare bacteria.
    Nurse Educ; 2013; 38(4):146. PubMed ID: 23778041
    [No Abstract]   [Full Text] [Related]  

  • 16. The new medical challenge: why NDM-1? Why Indian?
    Walsh TR; Toleman MA
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):137-41. PubMed ID: 21342058
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010.
    Huang CC; Chen YS; Toh HS; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Xu Y; Ni Y; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S4-10. PubMed ID: 22749058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. United States Centers for Disease Control and Prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae.
    Kallen A; Guh A
    Euro Surveill; 2012 Jun; 17(26):. PubMed ID: 22790535
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbapenem resistance in Enterobacteriaceae: here is the storm!
    Nordmann P; Dortet L; Poirel L
    Trends Mol Med; 2012 May; 18(5):263-72. PubMed ID: 22480775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology of multiresistance in Enterobacteria].
    Martínez Martínez L
    Rev Esp Quimioter; 2006 Mar; 19(1):87-8. PubMed ID: 16688300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.